155 related articles for article (PubMed ID: 19092288)
1. Prevalence and causes of undiagnosed hyperthyroidismin an adult healthy population. The Tromsø study.
Bjørndal MM; Sandmo Wilhelmsen K; Lu T; Jorde R
J Endocrinol Invest; 2008 Oct; 31(10):856-60. PubMed ID: 19092288
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.
Rieu M; Bekka S; Sambor B; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1993 Jul; 39(1):67-71. PubMed ID: 8348708
[TBL] [Abstract][Full Text] [Related]
3. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management.
Díez JJ
Gerontology; 2003; 49(5):316-23. PubMed ID: 12920352
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves' disease.
van Soestbergen MJ; van der Vijver JC; Graafland AD
J Endocrinol Invest; 1992 Dec; 15(11):797-800. PubMed ID: 1283983
[TBL] [Abstract][Full Text] [Related]
5. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
[TBL] [Abstract][Full Text] [Related]
6. Thyroid status and the levels of thyroid auto-antibodies in the sera of hyperthyroid and goitrous subjects.
Chinyanga EA; Benni A; Siziya S
Cent Afr J Med; 2000 Sep; 46(9):251-5. PubMed ID: 11320772
[TBL] [Abstract][Full Text] [Related]
7. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
[TBL] [Abstract][Full Text] [Related]
8. Development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake.
Kristensen HL; Vadstrup S; Knudsen N; Siersbaek-Nielsen K
J Endocrinol Invest; 1995 Jan; 18(1):41-3. PubMed ID: 7759783
[TBL] [Abstract][Full Text] [Related]
9. Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.
Arai N; Inaba M; Ichijyo T; Kagami H; Mine Y
J Med Case Rep; 2017 Jan; 11(1):9. PubMed ID: 28061802
[TBL] [Abstract][Full Text] [Related]
10. The role of thyroid scanning in hyperthyroidism.
Fogelman I; Cooke SG; Maisey MN
Eur J Nucl Med; 1986; 11(10):397-400. PubMed ID: 3009197
[TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
[TBL] [Abstract][Full Text] [Related]
13. Serum TSH levels in smokers and non-smokers. The 5th Tromsø study.
Jorde R; Sundsfjord J
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):343-7. PubMed ID: 16915535
[TBL] [Abstract][Full Text] [Related]
14. Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume.
Pfeilschifter J; Ziegler R
Eur J Endocrinol; 1997 Jan; 136(1):81-6. PubMed ID: 9037131
[TBL] [Abstract][Full Text] [Related]
15. The lack of nocturnal serum thyrotropin surge in patients with nontoxic nodular goiter may predict the subsequent occurrence of hyperthyroidism.
Bartalena L; Martino E; Velluzzi F; Piga M; Petrini L; Loviselli A; Grasso L; Pinchera A
J Clin Endocrinol Metab; 1991 Sep; 73(3):604-8. PubMed ID: 1874936
[TBL] [Abstract][Full Text] [Related]
16. Hemiaplasia of the thyroid with thyrotoxicosis.
Mortimer PS; Tomlinson IW; Rosenthal FD
J Clin Endocrinol Metab; 1981 Jan; 52(1):152-5. PubMed ID: 7451642
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 99mTc-methoxyisobutyl isonitrile and 201T1 scintigraphy in visualization of suppressed thyroid tissue.
Erdil TY; Onsel C; Kanmaz B; Caner B; Sönmezoğlu K; Ciftçi I; Turoğlu T; Kabasakal L; Sayman HB; Uslu I
J Nucl Med; 2000 Jul; 41(7):1163-7. PubMed ID: 10914905
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
[TBL] [Abstract][Full Text] [Related]
19. [Autonomy of the thyroid gland: is there an "organ hyperthyroidism" of "euthyroid" patients?].
Wawrzyn H; Hesch RD
Med Klin (Munich); 2000 Aug; 95(8):421-8. PubMed ID: 10985062
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
